How Due Diligence in Accurate Adverse Event Reporting is the Key to a clean FDA Audit 2011

This webinar is focused on How Due Diligence in Accurate Adverse Event Reporting is the Key to a clean FDA Audit 2011.

This webinar on How Due Diligence in Accurate Adverse Event Reporting is the Key to a clean FDA Audit 2011, brings together Clinical Research Scientists, investigators involved in the legal, regulatory and ethical issues in pharmaceutical product (Drug or device) research, Clinical Research Associates (CRAs), Safety Nurses, Clinical Research Data managers and QA / QC auditors.